INDRE DOYLE: Open Payments
NPI 1417320581 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$945 in 45 payments from 17 companies in 2025. Trend: 2023 $193 · 2024 $549 · 2025 $945
Food & beverage: $945
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $256 |
| Lilly USA, LLC | 9 | $162 |
| Abbott Laboratories | 4 | $86 |
| Novo Nordisk Inc | 4 | $72 |
| Tandem Diabetes Care, Inc. | 1 | $49 |
| Sequel Med Tech, LLC | 2 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
| Alexion Pharmaceuticals, Inc. | 2 | $34 |
| Insulet Corporation | 1 | $30 |
Products named: EVENITY, MOUNJARO, FREESTYLE LIBRE 3, JARDIANCE, t:slim X2 Insulin Pump with Control-IQ, TWIIST, Kerendia, DUPIXENT.
Industry payments across MD — which companies pay providers there.
